(Q40824677)

24 September 2017

title

Comparative clinical, microbiologic, and economic audit of the use of oral ciprofloxacin and parenteral antimicrobials (English)

1 reference

24 September 2017

J Cooke

1

1 reference

24 September 2017

C J Cairns

2

1 reference

24 September 2017

G S Tillotson

3

1 reference

24 September 2017

S Conner

4

1 reference

24 September 2017

S K Lewin

5

1 reference

24 September 2017

J Nicholls

6

1 reference

24 September 2017

R L Tredree

7

1 reference

24 September 2017

J V Willis

8

1 reference

24 September 2017

C R Hitchings

9

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 June 1993

1 reference

Annals of Pharmacotherapy

24 September 2017

published in

1 reference

24 September 2017

volume

27

1 reference

24 September 2017

issue

6

1 reference

24 September 2017

page(s)

785-789

1 reference

The responsibility of the infectious disease community for the optimal use of antimicrobial agents.

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700621

Antimicrobial therapy. Cost-benefit considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700621

The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700621

Oral ciprofloxacin therapy of infection caused by multiply resistant bacteria other than Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700621

A clinical, microbiological and pharmacokinetic study of ciprofloxacin plus vancomycin as initial therapy of febrile episodes in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700621

Oral ciprofloxacin compared with conventional intravenous treatment for Pseudomonas aeruginosa infection in adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700621

Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700621

Cost-effective choice of antimicrobial therapy for serious infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700621

The use of an antibiotic order form for antibiotic utilization review: influence on physicians' prescribing patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700621

APACHE II: a severity of disease classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700621

A proposed classification of intra-abdominal infections. Stratification of etiology and risk for future therapeutic trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700621

Economic evaluation of gastric ulcer prophylaxis in patients with arthritis receiving non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700621

The effect of cyclosporine on the use of hospital resources for kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700621

Acute myeloblastic leukaemia--a model for assessing value for money for new treatment programmes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700621

10.1177/106002809302700621

21 January 2018

Identifiers

DOI

0 references

1 reference